2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

OBJECTIVE The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present work, by a joint committee of the ACR and the European League Against Rheumatism (EULAR), was undertaken for the purpose of developing new classification criteria for SSc. METHODS Using consensus methods, 23 candidate items were arranged in a multicriteria additive point system with a threshold to classify cases as SSc. The classification system was reduced by clustering items and simplifying weights. The system was tested by 1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and 2) validating against the combined view of a group of experts on a set of cases with or without SSc. RESULTS It was determined that skin thickening of the fingers extending proximal to the metacarpophalangeal joints is sufficient for the patient to be classified as having SSc; if that is not present, 7 additive items apply, with varying weights for each: skin thickening of the fingers, fingertip lesions, telangiectasia, abnormal nailfold capillaries, interstitial lung disease or pulmonary arterial hypertension, Raynaud's phenomenon, and SSc-related autoantibodies. Sensitivity and specificity in the validation sample were, respectively, 0.91 and 0.92 for the new classification criteria and 0.75 and 0.72 for the 1980 ACR classification criteria. All selected cases were classified in accordance with consensus-based expert opinion. All cases classified as SSc according to the 1980 ACR criteria were classified as SSc with the new criteria, and several additional cases were now considered to be SSc. CONCLUSION The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria for SSc and should allow for more patients to be classified correctly as having the disease.

[1]  F. Perez-Ruiz,et al.  Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout , 2015, Arthritis care & research.

[2]  A. Ogdie,et al.  Distinctions Between Diagnostic and Classification Criteria? , 2015, Arthritis care & research.

[3]  A. Ogdie,et al.  Imaging modalities for the classification of gout: systematic literature review and meta-analysis , 2014, Annals of the rheumatic diseases.

[4]  M. Doherty,et al.  Identification of patients with gout: elaboration of a questionnaire for epidemiological studies , 2014, Annals of the rheumatic diseases.

[5]  M. Doherty,et al.  Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study , 2014, BDJ.

[6]  S. Nicolaou,et al.  Artifacts in dual-energy CT gout protocol: a review of 50 suspected cases with an artifact identification guide. , 2014, AJR. American journal of roentgenology.

[7]  P. Clerson,et al.  SAT0544 Prevalence of Gout in the Adult Population of France in 2013 , 2014 .

[8]  M. Mayes,et al.  Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. , 2014, Journal of clinical epidemiology.

[9]  E. Naredo,et al.  Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout? , 2013, Annals of the rheumatic diseases.

[10]  Mayes,et al.  Systemic Sclerosis Classification Criteria: Developing methods for multi-criteria decision analysis with 1000Minds , 2014 .

[11]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[12]  W. Taylor,et al.  New classification criteria for gout: a framework for progress. , 2013, Rheumatology.

[13]  L. Harrold,et al.  Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. , 2013, Rheumatology.

[14]  W. Taylor,et al.  AB0629 A critical appraisal of the competence of crystal identification by rheumatologists. , 2013 .

[15]  R. Terkeltaub,et al.  A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria , 2013, The Journal of Rheumatology.

[16]  W. Grassi,et al.  Tips and tricks to recognize microcrystalline arthritis. , 2012, Rheumatology.

[17]  M. Baron,et al.  Validation of potential classification criteria for systemic sclerosis , 2012, Arthritis care & research.

[18]  P. Merkel,et al.  Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise , 2012, Arthritis care & research.

[19]  A. Kerr,et al.  Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. , 2012, The New Zealand medical journal.

[20]  Shuai Leng,et al.  Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation. , 2011, Radiology.

[21]  Hyon K. Choi,et al.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.

[22]  E. Hachulla,et al.  Diagnosis and Classification of Systemic Sclerosis , 2011, Clinical reviews in allergy & immunology.

[23]  M. L. Lopes,et al.  Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group , 2010, Annals of the rheumatic diseases.

[24]  R. Steele,et al.  Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis. , 2010, Clinical and experimental rheumatology.

[25]  A. Silman,et al.  The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. , 2010, Arthritis and rheumatism.

[26]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[27]  I. Peláez-Ballestas,et al.  Diagnosis of Chronic Gout: Evaluating the American College of Rheumatology Proposal, European League Against Rheumatism Recommendations, and Clinical Judgment , 2010, The Journal of Rheumatology.

[28]  C. van Weel,et al.  A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. , 2010, Archives of internal medicine.

[29]  K. Liao,et al.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[30]  D. M. van der Heijde,et al.  The prognostic value of baseline erosions in undifferentiated arthritis , 2009, Arthritis research & therapy.

[31]  H. Schumacher,et al.  Clinical Diagnostic Criteria for Gout: Comparsion With the Gold Standard of Synovial Fluid Crystal Analysis , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[32]  D. M. van der Heijde,et al.  Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature , 2008, Annals of the rheumatic diseases.

[33]  M. Abrahamowicz,et al.  Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. , 2008, Arthritis and rheumatism.

[34]  Andrew Filer,et al.  Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. , 2008, Arthritis and rheumatism.

[35]  P. Hansen,et al.  A new method for scoring additive multi‐attribute value models using pairwise rankings of alternatives , 2008 .

[36]  L. Annemans,et al.  Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005 , 2007, Annals of the rheumatic diseases.

[37]  Michael H Weisman,et al.  New therapies for treatment of rheumatoid arthritis , 2007, The Lancet.

[38]  J. Singh,et al.  Classification criteria in rheumatic diseases: a review of methodologic properties. , 2007, Arthritis and rheumatism.

[39]  M. Dougados,et al.  Classification criteria for rheumatic diseases: why and how? , 2007, Arthritis and rheumatism.

[40]  M. Weinblatt,et al.  Optimal use of methotrexate: the advantages of tight control , 2007, Annals of the rheumatic diseases.

[41]  M. Matucci Cerinic,et al.  Nailfold capillaroscopy and classification criteria for systemic sclerosis. , 2007, Clinical and experimental rheumatology.

[42]  R. Steele,et al.  Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. , 2007, Clinical and experimental rheumatology.

[43]  M. Hudson,et al.  The development of systemic sclerosis classification criteria , 2007, Clinical Rheumatology.

[44]  R. Steele,et al.  Office capillaroscopy in systemic sclerosis , 2007, Clinical Rheumatology.

[45]  M. Dougados,et al.  Development of classification and response criteria for rheumatic diseases. , 2006, Arthritis and rheumatism.

[46]  A. Silman,et al.  Reconciling subject differences in recruitment to clinical trials and clinical practice. , 2005, The Journal of rheumatology.

[47]  Wei Chen,et al.  Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. , 2005, Arthritis and rheumatism.

[48]  F. Wollheim.  Classification of systemic sclerosis. Visions and reality. , 2005, Rheumatology.

[49]  E. Massarotti,et al.  Rheumatoid Arthritis: An Overview of New and Emerging Therapies , 2005, Journal of clinical pharmacology.

[50]  W. Bilker,et al.  Gout epidemiology: results from the UK General Practice Research Database, 1990–1999 , 2005, Annals of the rheumatic diseases.

[51]  V. Steen.  Autoantibodies in systemic sclerosis. , 1996, Seminars in arthritis and rheumatism.

[52]  M. Fritzler,et al.  A proposal of criteria for the classification of systemic sclerosis. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[53]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[54]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[55]  T. Pincus,et al.  Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[56]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[57]  A. Silman,et al.  Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. , 2003, Arthritis and rheumatism.

[58]  M. Uffmann,et al.  Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. , 2002, The Journal of rheumatology.

[59]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[60]  J. Raynauld,et al.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. , 2001, Arthritis and rheumatism.

[61]  B. Pal,et al.  How is Gout Managed in Primary Care? A Review of Current Practice and Proposed Guidelines , 2000, Clinical Rheumatology.

[62]  F. Wolfe,et al.  Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. , 1998, Arthritis and rheumatism.

[63]  P. Jones,et al.  Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. , 1998, The Journal of rheumatology.

[64]  K. Bohndorf,et al.  Diagnostic radiography in rheumatoid arthritis: benefits and limitations. , 1996, Bailliere's clinical rheumatology.

[65]  A. van der Heide,et al.  The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.

[66]  D. Felson,et al.  Methodological and statistical approaches to criteria development in rheumatic diseases. , 1995, Bailliere's clinical rheumatology.

[67]  D. van der Heijde,et al.  Joint erosions and patients with early rheumatoid arthritis. , 1995, British journal of rheumatology.

[68]  K. Aho,et al.  Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. , 1993, The Journal of rheumatology.

[69]  T. Pincus,et al.  What is the natural history of rheumatoid arthritis? , 1993, Rheumatic diseases clinics of North America.

[70]  H. Isomäki.  Long-term outcome of rheumatoid arthritis. , 1992, Scandinavian journal of rheumatology. Supplement.

[71]  T. Tuomi,et al.  Rheumatoid factors antedating clinical rheumatoid arthritis. , 1991, The Journal of rheumatology.

[72]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[73]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[74]  D. Symmons,et al.  LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS , 1987, The Lancet.

[75]  J. Fries,et al.  Survival, prognosis, and causes of death in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[76]  T. Pincus,et al.  Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.

[77]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[78]  H. Maricq,et al.  A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. , 1982, The American journal of medicine.

[79]  Maricq Hr,et al.  Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. , 1982 .

[80]  H. Maricq,et al.  Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. , 1982, The Journal of rheumatology.

[81]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[82]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[83]  A. Masi,et al.  Methods and preliminary results of the scleroderma criteria cooperative study of the American Rheumatism Association , 1979 .

[84]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[85]  J. S. Lawrence,et al.  The Epidemiology of Chronic Rheumatism , 1964 .